ioversol

09/01/1991 - "The diagnostic efficacy of ioversol was equivalent or superior to that of the reference products and tolerance was comparable to that of nonionic agents in terms of pain and heat sensations. "
02/01/1990 - "Assessment of pain was also comparable (2 patients in the ioversol-240 group and 1 in the ioversol-320 group). "
06/01/1989 - "Heat and pain related to injection of ioversol were graded on a four-point scale, with 0 indicating none and 3 indicating severe. "
06/01/1989 - "Ioversol was better tolerated, as evidenced by significantly lower pain and heat scores. "
11/15/2014 - "The incidence of pain has been around 50% of the all population in study, with lesser incidence of pain (25.7% vs 74.3%; P < 0.0001) and of heat sensation (55.4% vs 85.1%; P < 0.0001), after Iodixanol than after Ioversol injection. "

08/01/2022 - "A systematic review of the incidence of hypersensitivity reactions and post-contrast acute kidney injury after ioversol in more than 57,000 patients: part 1-intravenous administration."
08/01/2022 - "A systematic review of the incidence of hypersensitivity reactions and post-contrast acute kidney injury after ioversol: part 2-intra-arterial administration."
01/01/2022 - "The aim of this study was to determine the prevalence of post-contrast acute kidney injury or comparable side effects on kidney function in cats receiving the non-ionic, iodinated agent ioversol and/or paramagnetic agent gadoteric acid. "
08/01/2022 - "To evaluate the incidence of adverse drug reactions (ADRs), including hypersensitivity reactions (HSRs) and post-contrast acute kidney injury (PC-AKI), after intravenous (IV) administration of ioversol. "
08/01/2022 - "To evaluate the incidence of adverse drug reactions (ADRs), including hypersensitivity reactions (HSRs) and post-contrast acute kidney injury (PC-AKI), after intra-arterial (IA) administration of ioversol. "

06/25/1990 - "A patient had a symptom of nausea after ioversol administration, but it was mild and transient and resolved spontaneously. "
01/01/2020 - "One and six patients experienced nausea for Iopamidol 250 and Ioversol 320, respectively. "
01/01/1992 - "Ioversol was well tolerated in the study with only two mild adverse reactions (nausea and vomiting, and metallic taste)."

10/01/2008 - "Nephrotoxicity of iodixanol versus ioversol in patients with chronic kidney disease: the Visipaque Angiography/Interventions with Laboratory Outcomes in Renal Insufficiency (VALOR) Trial."
07/01/2013 - "A modified model of gentamicin induced renal failure in rats: toxicological effects of the iodinated X-ray contrast media ioversol and potential usefulness for toxicological evaluation of iodinated X-ray contrast media."

07/11/2017 - "Furthermore, in vivo ioversol CEST MRI, we were able to map relative pHe and differentiate between tumor and normal tissue in a McA-RH7777 rat hepatoma model. "
01/01/2020 - "This study aimed to compare the image quality and adverse events between Iopamidol 250 and Ioversol 320 usage during transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma (HCC). "